![Daniel J. Speciale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel J.
Speciale currently works at Kindeva Drug Delivery LP, as Co-Chief Financial Officer and Mallinckrodt Pharmaceuticals Ltd., as VP-Investor Relations & Investor Relations Officer.
Mr. Speciale also formerly worked at Mallinckrodt Plc, as VP-Investor Relations & Investor Relations Officer.
Mr. Speciale received his undergraduate degree and graduate degree from Gies College of Business.
| Companies | Position | Start |
|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Investor Relations Contact | - |
Kindeva Drug Delivery LP
 Kindeva Drug Delivery LP Medical SpecialtiesHealth Technology Operates as a drug delivery contract development and manufacturing organization | Director of Finance/CFO | 01/01/2025 |
| Companies | Position | End |
|---|---|---|
| MALLINCKRODT PLC | Investor Relations Contact | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gies College of Business
 Gies College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kindeva Drug Delivery LP
Kindeva Drug Delivery LP Medical SpecialtiesHealth Technology Operates as a drug delivery contract development and manufacturing organization | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
